Skip to Content
Uncategorized

Cynthia Kenyon Declines

Cynthia Kenyon, a biogerontologist at UCSF, has declined to review Aubrey de Grey’s Strategies for Engineered Negligible Senescence (SENS). De Grey, a computer scientist and theoretical biologist at the University of Cambridge, believes he can defeat human aging within…

Cynthia Kenyon, a biogerontologist at UCSF, has declined to review Aubrey de Grey’s Strategies for Engineered Negligible Senescence (SENS). De Grey, a computer scientist and theoretical biologist at the University of Cambridge, believes he can defeat human aging within the lifetime of those now living. I asked Dr. Kenyon if she would comment on de Grey’s prescriptions almost three months ago; she agreed; and I announced her “By Invitation” column on this blog last week, asking readers what issues they would like her to address. But after a great deal of work, Dr. Kenyon very graciously told me she simply felt she couldn’t do an “effective” job. I remain committed to finding a biologist who will criticize SENS: after Technology Review’s profile of de Grey, Do You Want to Live Forever?, many of his admirers challenged me to have a working scientist say why de Grey’s ideas were impractical–if they were impractical. So far, I have been unable to find one biogerontologist who felt comfortable writing about SENS–which is telling perhaps. But I shan’t give up yet.

Deep Dive

Uncategorized

Uber Autonomous Vehicles parked in a lot
Uber Autonomous Vehicles parked in a lot

It will soon be easy for self-driving cars to hide in plain sight. We shouldn’t let them.

If they ever hit our roads for real, other drivers need to know exactly what they are.

stock art of market data
stock art of market data

Maximize business value with data-driven strategies

Every organization is now collecting data, but few are truly data driven. Here are five ways data can transform your business.

Cryptocurrency fuels new business opportunities

As adoption of digital assets accelerates, companies are investing in innovative products and services.

Mifiprex pill
Mifiprex pill

Where to get abortion pills and how to use them

New US restrictions could turn abortion into do-it-yourself medicine, but there might be legal risks.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.